Weekly Cisplatin plus Capecitabine is an active regimen in heavily pretreated advanced breast cancer patients

被引：0
|
作者：
Donadio, Michela [1 ]
Beano, Alessandra [1 ]
Ardine, Mara [1 ]
Bonardi, Simone [2 ]
Mistrangelo, Marinella [1 ]
Polimeni, Maria A. [1 ]
Castiglione, Federico [3 ]
Forti, Laura [4 ]
Bottini, Alberto [2 ]
Bertetto, Oscar [1 ]
机构：
[1] Azienda Osped San Giovanni Battista, COES, Turin, Italy
[2] Azienda Osped Ist Ospetalieri, Cremona, Italy
[3] Osped San Lazzaro, Alba, Italy
[4] Osped Maggiore La Carita, SCDU Oncol Med, Novara, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [41] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Zhang, Pin
    Tong, Zhongsheng
    Tian, Fuguo
    Wang, Yongsheng
    Yang, Junlan
    Li, Weilian
    Di, Lijun
    Liu, Wei
    Tang, Li
    Qiu, Rongguo
    Xu, Binghe
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [42] ADHERENCE TO AND PERSISTENCE WITH AN ORAL METRONOMIC CHEMOTHERAPY WITH CAPECITABINE IN HEAVILY PRETREATED METASTATIC BREAST CANCER (MBC) PATIENTS
    Mazzoni, E.
    Fedele, P.
    Orlando, L.
    Marino, A.
    D'Amico, M.
    Sponziello, F.
    Nacci, A.
    Calvani, N.
    Schiavone, P.
    Rizzo, P.
    Chetri, M. C.
    Cinieri, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S101 - S101
  • [43] Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
    Pin Zhang
    Zhongsheng Tong
    Fuguo Tian
    Yongsheng Wang
    Junlan Yang
    Weilian Li
    Lijun Di
    Wei Liu
    Li Tang
    Rongguo Qiu
    Binghe Xu
    Journal of Hematology & Oncology, 9
  • [44] Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer
    Martinez Marin, Virginia
    Munoz Martin, Andres J.
    Vinuela Beneitez, M. Carmen
    Garcia Alfonso, Pilar
    Alonso Munoz, Antonio
    Perez Manga, Gumersindo
    MEDICINA CLINICA, 2009, 133 (10): : 371 - 374
  • [45] Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer
    Gennatas, C
    Michalaki, V
    Mouratidou, D
    Tsavaris, N
    Andreadis, C
    Psychogios, J
    Poulakaki, N
    ANTICANCER RESEARCH, 2006, 26 (1B) : 549 - 552
  • [46] Capecitabine/vinorelbine:: An effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer
    Nole, Franco
    Catania, Chiara
    Munzone, Elisabetta
    Rocca, Andrea
    Verri, Elena
    Sanna, Giuseppina
    Ascione, Gilda
    Adamoli, Laura
    Zampino, Maria G.
    Minchella, Ida
    Goldhirsch, Aron
    CLINICAL BREAST CANCER, 2006, 6 (06) : 518 - 524
  • [47] Mitoxantrone plus gemcitabine in pretreated patients with advanced breast cancer.
    Onyenadum, A
    Kosmidis, P
    Aravantinos, G
    Bafaloukos, D
    Gogas, H
    Bacoyiannis, C
    Razis, E
    Markopoulos, C
    Makatsoris, T
    Kalofonos, HP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 83S - 83S
  • [48] Mitoxantrone plus vinorelbine in pretreated patients with advanced breast cancer.
    Onyenadum, A
    Gogas, H
    Markopoulos, C
    Bafaloukos, D
    Aravantinos, G
    Koutras, A
    Makatsoris, T
    Koukouras, D
    Pavlidis, N
    Kalofonos, HP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 93S - 93S
  • [49] 5FU Continuous Infusion in Heavily Pretreated Advanced Breast Cancer Patients
    Regierer, Anne C.
    Reinecke, Franziska
    Weigel, Andrea
    Dieing, Annette
    Lehenbauer-Dehm, Silvia
    Schwarzlose-Schwarck, Sandra
    Possinger, Kurt
    Eucker, Jan
    ONKOLOGIE, 2011, 34 (12): : 696 - 700
  • [50] A WEEKLY SCHEDULE OF EPIRUBICIN IN PRETREATED ADVANCED BREAST-CANCER
    BARNI, S
    ARCHILI, C
    LISSONI, P
    PAOLOROSSI, F
    CRISPINO, S
    TANCINI, G
    TUMORI, 1993, 79 (01) : 45 - 48
12345